Benzinga | Aug 3, 2021 04:53PM EDT

Pacific Biosciences Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $30.60M Beat $29.89M Estimate

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.20) by 5 percent. This is a 40 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $30.60 million which beat the analyst consensus estimate of $29.89 million by 2.38 percent. This is a 79.19 percent increase over sales of $17.08 million the same period last year.